APP and Parkinson disease: The specific cancer cell lines were injected subcutaneously and tumor growth rates and final tumor volumes were compared between the A53T α-Syn+/+ mice, modeling PD; APP/PS1, modeling AD; and control genotypes including, F1 B6/C3H, B6 and C3H.